ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 2675

The Selective Loss of SLAMF4+ CD8+ T Cells Contributes to the Decreased Cytotoxic Capacity Observed in Systemic Lupus Erythematosus

Katalin Kis-Toth1, Denis Comte1, Maria Karampetsou1, Lakshmi Kannan2 and George C. Tsokos1, 1Rheumatology, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA, 2Rheumtology, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Save to PDF
Session Information

Session Title: Systemic Lupus Erythematosus - Human Etiology and Pathogenesis: T and B Cell Signaling and Genetic Variants

Session Type: Abstract Submissions (ACR)

Background/Purpose

Signaling lymphocytic activation molecule family member 4 (SLAMF4) engagement by its ligand SLAMF2 can mediate the cytotoxicity of CD8+ T cells and natural killer cells. SLE CD8+ T lymphocytes are reportedly defective in cytotoxicity. The aim of this study was to investigate the expression and function of SLAMF4 on SLE CD8+ T cells.

Methods

The expression of SLAMF4 and its adaptor SAP in healthy and SLE T cells were measured by Q-PCR, flow cytometry and western blot. T cells were treated by immobilized anti-SLAMF4 antibodies and the cytotoxic capacity of the T cells was monitored by the cell surface expression of CD107a, reflecting exocytosis of lytic granules.

Results

We found significant downregulation of SLAMF4 and the adaptor molecule SAP gene and protein expression in SLE T cells compared to normal controls. Characterization of the T cell subsets revealed that SLE patients have significantly less SLAMF4+ CD8+ T cells compared to normal control T cells, switching the SLAMF4+/SLAMF4– ratio in the favor of SLAMF4– CD8+ T cells which have less SAP expression and decreased cytotoxic capacity. SLAMF4 engagement triggers the degranulation of CD8+ T cells and SLE T cells have decreased degranulation capacity compared to normal controls. In the effort to explain the loss of SLAMF4+ CD8+ T cells in SLE we found that these cells are more likely become double negative T cells and/or die by apoptosis. 

Conclusion

Based on our results we conclude that the selective loss of SLAMF4+ CD8+ T cells may contribute to the ineffective capacity of fighting against infections in SLE.


Disclosure:

K. Kis-Toth,
None;

D. Comte,
None;

M. Karampetsou,
None;

L. Kannan,
None;

G. C. Tsokos,
None.

  • Tweet
  • Email
  • Print
Save to PDF

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-selective-loss-of-slamf4-cd8-t-cells-contributes-to-the-decreased-cytotoxic-capacity-observed-in-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.